Featured Strategy

Mirae Asset

Balanced exposure to equities and gold for diversification across market cycles and risk regimes.

Learn more
CategoryMulti-Asset Allocation
No. of ETFs4 ETFs
Review CycleMonthly Review
Horizon3–5 Years

Performance

How this portfolio has performed

Compare growth against a benchmark across timelines and see what a hypothetical investment would be worth today.

In the period of
Amount (₹)00.3K0.5K0.8K1K1.3KOctDecFebAprJunAugTime

Overview

Understand this portfolio

Key metrics, suitability, and strategy highlights to help you evaluate whether this model portfolio fits your goals.

Investment Objective

Equity growth with gold hedge

Pair equity growth with a gold allocation to participate in markets while cushioning volatility. Built for investors who want upside exposure with a defensive hedge in uncertain phases.

No. of ETFs

4 ETFs

Suggested Horizon

3–5 Years

Review Cycle

Monthly

Min. Investment

₹5,000

Who this may be suitable for

Investors who want equity participation with a gold allocation to help cushion volatility during uncertain market phases.

What investors should keep in mind

Gold may not always rise when equities fall. The portfolio can still experience meaningful short-term swings depending on market regime.

  • Equity and gold combination
  • Diversification across market cycles
  • ETF-only transparent structure
  • Periodic review and rebalance

Holdings

Portfolio constituents and weights

Review the ETF mix and segment allocation that defines this model portfolio.

Log in to view holdings and allocation details

FAQs

Got questions? We've got answers!

Common questions about Mirae Asset Equity Gold and what to expect when you invest.

Mirae Asset Equity Gold combines large-cap and mid-cap equity ETF exposure with a meaningful gold allocation and a liquid debt sleeve for stability.

Collateral

Documents and timelines

Download portfolio documents and review the scheduled rebalance checkpoints for this strategy.

Rebalance Timelines

  • Q1 Review — January 2026

    Quarterly allocation check against model targets and drift thresholds.

  • Q2 Review — April 2026

    Mid-year review of macro signals, risk metrics, and sleeve performance.

  • Q3 Review — July 2026

    Thematic and factor sleeve review with updated market regime assessment.

  • Q4 Review — October 2026

    Year-end reset to target weights and annual strategy documentation update.